BCPEM
ABBV icon

Bain Capital Public Equity Management’s AbbVie ABBV Stock Holding History

Bain Capital Public Equity Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-30,000
Closed -$150K – 34
2015
Q4 		$150K Sell
30,000
-2,970,000
-99% -$171M ﹤0.01% 35
2015
Q3 		$825K Buy
+3,000,000
New +$195M 0.02% 38

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bain Capital Public Equity Management's ABBV Position: Q1 2016 in Review

Bain Capital Public Equity Management sold out of AbbVie (ABBV) in Q1 2016, closing a stake of 1,588,831 shares — an estimated $94.1M sold.

Bain Capital Public Equity Management first reported a position in ABBV in Q2 2014 and held it in 7 quarters. The position peaked at $265M in Q2 2015. 1,639 funds tracked by Wall St. Rank hold ABBV as of Q1 2016.

  • Bain Capital Public Equity Management reported no remaining AbbVie position as of Q1 2016 after selling out during the quarter.
  • Bain Capital Public Equity Management sold 1,588,831 AbbVie shares in Q1 2016, an estimated $94.1M.
  • Bain Capital Public Equity Management first reported a position in AbbVie in Q2 2014 and held it in 7 quarters.
  • Bain Capital Public Equity Management's AbbVie position peaked at $265M in Q2 2015.
  • 1,639 funds tracked by Wall St. Rank held AbbVie as of Q1 2016.

Based on Bain Capital Public Equity Management's 13F filing for Q1 2016, filed 16 May 2016.